OS 01-07 CLINICAL IMPORTANCE OF COLLAGEN METABOLISM MARKERS IN RHEUMATIC HEART VALVE DISEASE IN INDIAN SUBPOPULATION

2016 ◽  
Vol 34 (Supplement 1) ◽  
pp. e46 ◽  
Author(s):  
Tanima Banerjee ◽  
Somaditya Mukherjee ◽  
Sudip Ghosh ◽  
Monodeep Biswas ◽  
Santanu Datta ◽  
...  
Global Heart ◽  
2014 ◽  
Vol 9 (1) ◽  
pp. e26
Author(s):  
Arun Bandyopadhyay ◽  
Tanima Banerjee ◽  
Somaditya Mukherjee ◽  
Monodeep Biswas ◽  
Sudip Ghosh ◽  
...  

2020 ◽  
Vol 33 (6) ◽  
pp. 329
Author(s):  
Shantanu Pande ◽  
SurendraK Agarwal ◽  
Prabhat Tewari ◽  
Vinita Agrawal ◽  
Nilesh Srivastav ◽  
...  

Circulation ◽  
2020 ◽  
Vol 142 (Suppl_3) ◽  
Author(s):  
Livia Passos ◽  
Mark C Blaser ◽  
Dayanna Romero ◽  
Dakota Becker Greene ◽  
Adrien Lupieri ◽  
...  

Introduction: Acute rheumatic fever (ARF) results from autoimmune responses to group A streptococcus. ARF can cause chronic rheumatic heart valve disease (RHVD), a major public health burden in low- and middle-income countries. Although ARF affects both sexes equally, females have a higher prevalence of RHVD. We identified a target protein, ProTα, that may contribute to pathophysiology of and gender predisposition in RHVD. Estradiol regulates ProTα, which influences transcriptional activity of the estrogen receptor (ER). Methods: Human heart valves (n=120) obtained from heart transplantation and valve replacement surgeries, including non-diseased mitral and aortic valves (NDMV and NDAV, n=17/group), rheumatic mitral and aortic valves (RMVD, n=45; RAVD, n=8) and calcifying valves from patients with calcific aortic valve disease (CAVD, n=33) underwent proteomic and network analyses, and immunohistochemical assessment of CD68, CD4, CD8 and ProTα. ProTα levels were measured in plasma and peripheral mononuclear cells (PBMCs) from RHVD patients and healthy donors (n=14/group) by ELISA and flow cytometry. Results: A comparison of proteomes from NDMV and NDAV established the baseline differences between valve types. 12 proteins were enriched (q<0.05) in NDMV that may indicate the mitral valve predisposition to RVHD. Proteome analysis of non-diseased and diseased valves (NDMV vs RMVD, NDAV vs RAVD) identified a total of 213 proteins enriched in RHVD (q<0.05). The expression of the 12 NDMV-enriched proteins were evaluated across the 213 proteins enriched in diseased valves, resulting in the identification of ProTα common to both the RMVD and RAVD proteomes, but absent in CAVD. Additional KEGG pathway enrichment analyses linked 6 among 213 proteins with the estrogen signaling pathway (p<0.05). Immunoreactive ProTα colocalized with T CD8 cells in RHVD. ProTα and ERα also correlated strongly in circulating T CD8 cells in RHVD (p<0.05). ProTα plasma levels were higher in RHVD patients than healthy individuals (2 fold, p<0.05). Conclusion: We propose that ProTα is a novel contributor to the immunopathogenesis of RHVD and may regulate sex predisposition in this disease.


2021 ◽  
Vol 7 ◽  
Author(s):  
Livia S. A. Passos ◽  
Maria Carmo P. Nunes ◽  
Elena Aikawa

Rheumatic heart valve disease (RHVD) is a post-infectious sequel of acute rheumatic fever resulting from an abnormal immune response to a streptococcal pharyngitis that triggers valvular damage. RHVD is the leading cause of cardiovascular death in children and young adults, mainly in women from low and middle-income countries. It is known that long-term inflammation and high degree of fibrosis leads to valve dysfunction due to anatomic disruption of the valve apparatus. However, since public and private investments in RHVD studies are practically inexistent the number of publications is scarce. This disease shows different natural history and clinical presentations as compared to other degenerative heart valve diseases. Although more than five decades passed after the pioneering studies on the pathogenesis of RHVD, it is still unclear how self-tolerance mechanisms fail in this disease, and how humoral and cellular inflammatory responses are interconnected. Despite that pathological mechanisms have been already proposed for RHVD, none of them are able to explain the preferential involvement of the mitral valve. This review focuses on pathophysiology and underlying mechanisms of RHVD.


1978 ◽  
Vol 41 (2) ◽  
pp. 302-307 ◽  
Author(s):  
Jeffrey S. Borer ◽  
David R. Redwood ◽  
Samuel B. Itscoitz ◽  
Robert E. Goldstein ◽  
Stephen E. Epstein

2017 ◽  
Vol 17 (1) ◽  
Author(s):  
Kangjun Shen ◽  
Hui Liu ◽  
Ran Jing ◽  
Jiangfeng Yi ◽  
Xinmin Zhou

Sign in / Sign up

Export Citation Format

Share Document